- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: Dexamethasone, Bortezomib, Doxorubicin
Total 5872 results
-
Janssen Korea, Ltd., KoreaCompletedMultiple Myeloma
-
Janssen Korea, Ltd., KoreaCompletedMultiple MyelomaKorea, Republic of
-
International Extranodal Lymphoma Study Group (IELSG)CompletedLymphoma, Mucosa-Associated Lymphoid TissueSwitzerland
-
Institute of Hematology & Blood Diseases Hospital...Recruiting
-
Southwest Oncology GroupNational Cancer Institute (NCI)TerminatedMultiple MyelomaUnited States
-
Memorial Sloan Kettering Cancer CenterNational Cancer Institute (NCI)CompletedOvarian Cancer | Fallopian Tube Cancer | Primary Peritoneal Cavity CancerUnited States
-
Massachusetts General HospitalDana-Farber Cancer Institute; Beth Israel Deaconess Medical Center; Brigham and...TerminatedMyelodysplastic SyndromeUnited States
-
Threshold PharmaceuticalsUnknown
-
AHS Cancer Control AlbertaTom Baker Cancer CentreRecruitingMyeloma | Myeloma MultipleCanada
-
European Organisation for Research and Treatment...CompletedMalignant MesotheliomaUnited Kingdom
-
OncotherapeuticsMillennium Pharmaceuticals, Inc.TerminatedMultiple MyelomaUnited States
-
Millennium Pharmaceuticals, Inc.Completed
-
University of ArkansasMillennium Pharmaceuticals, Inc.TerminatedMultiple MyelomaUnited States
-
University Health Network, TorontoNational Cancer Institute (NCI)CompletedColorectal CancerCanada
-
Janssen Pharmaceutica N.V., BelgiumCompleted
-
Cancer Trials IrelandCompleted
-
CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co....RecruitingRelapsed or Refractory Multiple MyelomaChina
-
Ida Bruun KristensenOdense Patient Data Explorative Network; Karyopharm Therapeutics IncActive, not recruitingMultiple MyelomaDenmark, Norway, Estonia
-
H. Lee Moffitt Cancer Center and Research InstituteJanssen Scientific Affairs, LLCActive, not recruitingMultiple MyelomaUnited States
-
University of KentuckyOrtho Biotech, Inc.TerminatedProstate CancerUnited States
-
Swiss Group for Clinical Cancer ResearchEuropean Mantle Cell Lymphoma NetworkTerminatedMantle Cell LymphomaItaly, Germany, Switzerland
-
National Cancer Institute (NCI)CompletedRecurrent Grade 1 Follicular Lymphoma | Recurrent Grade 2 Follicular Lymphoma | Recurrent Grade 3 Follicular Lymphoma | Recurrent Mantle Cell LymphomaUnited States
-
National Cancer Institute (NCI)TerminatedAdult Anaplastic Astrocytoma | Adult Anaplastic Oligodendroglioma | Adult Giant Cell Glioblastoma | Adult Glioblastoma | Adult Gliosarcoma | Recurrent Adult Brain TumorUnited States
-
National Cancer Institute (NCI)CompletedRecurrent Adult Acute Myeloid Leukemia | Adult Acute Promyelocytic Leukemia (M3) | Previously Treated Myelodysplastic Syndromes | Recurrent Adult Acute Lymphoblastic Leukemia | Relapsing Chronic Myelogenous Leukemia | Refractory Anemia With Excess Blasts | Blastic Phase Chronic Myelogenous Leukemia and other conditionsUnited States
-
Millennium Pharmaceuticals, Inc.CompletedMantle Cell LymphomaUnited States
-
Millennium Pharmaceuticals, Inc.CompletedProstatic NeoplasmsUnited States
-
Hackensack Meridian HealthGenentech, Inc.TerminatedA Phase II Study of Bevacizumab and Bortezomib in Patients With Relapsed/Refractory Multiple MyelomaMultiple MyelomaUnited States
-
Millennium Pharmaceuticals, Inc.Johnson & Johnson Pharmaceutical Research & Development, L.L.C.CompletedMultiple MyelomaUnited States
-
National Cancer Institute (NCI)TerminatedStage IIIB Non-small Cell Lung Cancer | Recurrent Non-small Cell Lung Cancer | Stage IV Non-small Cell Lung CancerUnited States
-
West of Scotland Lymphoma GroupCompletedMultiple Myeloma and Plasma Cell NeoplasmUnited Kingdom
-
Eastern Cooperative Oncology GroupNational Cancer Institute (NCI); European Organisation for Research and Treatment... and other collaboratorsCompletedMultiple Myeloma and Plasma Cell NeoplasmUnited States, Canada
-
Southwest Oncology GroupNational Cancer Institute (NCI)Completed
-
M.D. Anderson Cancer CenterMillennium Pharmaceuticals, Inc.Active, not recruitingSolid Tumor | Urethral CancerUnited States
-
University of PittsburghNovartisWithdrawnMultiple Myeloma | Multiple Myeloma in RelapseUnited States
-
University of ArkansasTerminatedMultiple MyelomaUnited States
-
The Rogosin InstituteWeill Medical College of Cornell UniversityCompleted
-
Cancer Trials IrelandCompletedMalignant MesotheliomaUnited Kingdom, Ireland, Belgium, Netherlands
-
University of BolognaJanssen-Cilag Ltd.Unknown
-
Prof. Dr. M. Dreyling (co-chairman)ClinAssess GmbH; Klinikum der Universitaet Muenchen, Grosshadern; GELARC Service...UnknownMantle Cell LymphomaFrance, Germany
-
University of Kansas Medical CenterMillennium Pharmaceuticals, Inc.CompletedAutologous Transplant | Malignant Lymphoma, Stem Cell TypeUnited States
-
Assistance Publique - Hôpitaux de ParisCompletedWaldenstrom MacroglobulinemiaFrance
-
Millennium Pharmaceuticals, Inc.CompletedMultiple MyelomaUnited States, United Kingdom, Canada, Israel, France, Austria, Belgium, Germany, Ireland, Italy, Netherlands, Spain, Sweden
-
University Hospital Plymouth NHS TrustCompleted
-
Janssen Research & Development, LLCCompleted
-
Centocor, Inc.WithdrawnMultiple MyelomaCanada, United States, Belgium, Poland, Bulgaria, Turkey, Ukraine, Australia, Korea, Republic of, New Zealand, Czech Republic, United Kingdom, Netherlands, India
-
Southwest Oncology GroupNational Cancer Institute (NCI)Withdrawn
-
Prof. Dr. Clemens SchmittCharite University, Berlin, Germany; Janssen-Cilag Ltd.Active, not recruitingDiffuse Large B Cell LymphomaGermany
-
Virginia Commonwealth UniversityCompletedMelanoma | Soft Tissue Sarcoma | Parathyroid Carcinoma | Small Cell Carcinoma of the Lung | Carcinoid TumorsUnited States